title: Reply to M. Mohiuddin et al.
authors.forename: Alice
authors.initials: A
authors.lastname: Dewdney
authors.forename: Eliza A
authors.initials: EA
authors.lastname: Hawkes
authors.forename: David
authors.initials: D
authors.lastname: Cunningham
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D004358:Drug Therapy / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods; D020360:Neoadjuvant Therapy / Q000379:methods*; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D013997:Time Factors; D016896:Treatment Outcome